Previous 10 | Next 10 |
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...
Trevi Therapeutics press release ( NASDAQ: TRVI ): Q2 GAAP EPS of -$0.14 beats by $0.04 . Company had total cash, cash equivalents and marketable securities of $78.9 million. For further details see: Trevi Therapeutics GAAP EPS of -$0.14 beats by $0.04 ...
Trevi Therapeutics Announces Second Quarter 2022 Financial Results and Business Update PR Newswire Reported positive results from the Phase 2b /3 PRISM trial of Haduvio™ in the treatment of Prurigo Nodularis Completed a $55 million private placem...
Trevi Therapeutics to Present at Upcoming August Conferences PR Newswire NEW HAVEN, Conn. , Aug. 9, 2022 /PRNewswire/ -- Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio ...
Trevi Therapeutics to Report Q2 2022 Financial Results and Provide a Corporate Update on August 11, 2022 PR Newswire Conference call and webcast to be held at 4:30 p.m. EDT NEW HAVEN, Conn. , Aug. 4, 2022 /PRNewswire/ -- Trevi Therapeutics, ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors are currently fearful of the stock market downtrend and aren’t as active in the market. Moreover, the risk of a recession has also discouraged any investments in the stock market. However, penny stock...
NEW YORK, NY / ACCESSWIRE / July 14, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Trevi Therapeutics. Mark Roberts, Senior Editor at Traders News...
Trevi Therapeutics to Attend the Twelfth London International Cough Symposium (12th LICS) PR Newswire NEW HAVEN, Conn. , July 7, 2022 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing an inv...
Tips for Finding Trending Penny Stocks to Buy Finding trending penny stocks can be a difficult task. And in 2022, there are plenty of things that make either penny stocks or blue chips trend in one direction or another. Because of this, investors need to understand stock market tren...
3 Trending Penny Stocks to Watch as June Ends Finding trending penny stocks to buy is not easy. Especially when we consider how much is going on in the stock market as of late, trending penny stocks are not easy to come by. However, with the right research on hand, we can find plent...
News, Short Squeeze, Breakout and More Instantly...
Trevi Therapeutics Inc. Company Name:
TRVI Stock Symbol:
NYSE Market:
Trevi Therapeutics Inc. Website:
Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events PR Newswire Two abstracts accepted for oral presentation at the 13 th London International Cough Symposium NEW HAVEN, Conn. , July 2, 2024 /PRNewswire/ -- Trevi Therapeutic...
Trevi Therapeutics to Participate in Upcoming Conferences PR Newswire NEW HAVEN, Conn. , May 9, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™...
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates PR Newswire Reaffirms guidance for the Phase 2a RIVER trial in refractory chronic cough and Human Abuse Potential (HAP) Study with topline data for each expected in the second half of...